Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function

Patent No. EP2376535 (titled "Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell Function") was filed by F Hoffmann LA Roche on Dec 8, 2009. The application was issued on Sep 13, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FURO VENTURESJan 12, 2018BREUER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2376535

F HOFFMANN LA ROCHE
Application Number
EP09764997A
Filing Date
Dec 8, 2009
Status
Revoked
Apr 12, 2023
Publication Date
Sep 13, 2017